If you have any question, please feel free to email us. We will touch with you as soon as possible.
Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65. For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
| Generic name | Methylphenidate Hydrochloride Extended-Release Tablets |
| Trade name | CONCERTA |
| Specification | 54 mg |
| Main ingredients | Methylphenidate Hydrochloride |
| Appearance | Capsule-shaped, imprinted with "M" in a box and "54" on one side in black ink |
| MA Holder | Janssen Pharmaceuticals Inc |
| Product Type | Reference Listed Drugs (RLDs) |
Indications:
Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children 6 years of age and older, adolescents, and adults up to the age of 65.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: Methylphenidate Hydrochloride Extended-Release Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Reference Listed Drugs, Acarbose Tablets, Bimatoprost Ophthalmic, Argatroban Injection, Olanzapine Tablets, Adefovir Dipivoxil Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
